Log in

Relevant bibliographies by topics / Irritable bowel syndrome - Homeopathic treatment / Journal articles

To see the other types of publications on this topic, follow the link: Irritable bowel syndrome - Homeopathic treatment.

Journal articles on the topic 'Irritable bowel syndrome - Homeopathic treatment'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Irritable bowel syndrome - Homeopathic treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Peckham, Emily, Jackie Raw, and Clare Relton. "Exploring the effectiveness of homeopathic treatment for irritable bowel syndrome." Homeopathy 103, no. 1 (January 2014): 90–91. http://dx.doi.org/10.1016/j.homp.2013.10.060.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Peckham, Emily J., Clare Relton, Jackie Raw, Clare Walters, Kate Thomas, Christine Smith, Kapil Kapur, and Elmuhtady Said. "Interim results of a randomised controlled trial of homeopathic treatment for irritable bowel syndrome." Homeopathy 103, no. 3 (July 2014): 172–77. http://dx.doi.org/10.1016/j.homp.2014.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Wandile, Pranali. "Fibromyalgia Management with Homeopathy." Homœopathic Links 30, no. 04 (December 2017): 245–49. http://dx.doi.org/10.1055/s-0037-1608614.

Full text

Abstract:

AbstractFibromyalgia is one of the most common genetically inherited chronic affective spectrum disorders (ASD). Other ASD disorders are psychiatric and medical conditions such as irritable bowel syndrome (IBS), migraine, cataplexy—attention-deficit/hyperactivity disorder, bulimia nervosa, dysthymic disorder, generalised anxiety disorder, major depressive disorder (MDD), obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, rheumatoid arthritis, and social phobia. Apart from genetic factors, neuroendocrine, autonomic nervous system abnormalities, psychosocial variables and environmental stressors contribute in the pathophysiology of fibromyalgia and other associated disorders. In this article, we reviewed etiology, pathophysiology, maintaining and triggering factors, and various treatment options for fibromyalgia. Apart from the pain management, this condition can be managed by ancillary method of treatment. However, due to the genetic cause of the disease, there is very little to offer for its complete cure. Homeopathic miasmatic treatment focuses on the genetic cause of the disease for its complete annihilation while also providing various acute remedies for the temporary pain management. We reviewed homeopathy treatment management and various remedies, which have much to offer for this chronic condition while considering its genetic, triggering and maintaining factors.

APA, Harvard, Vancouver, ISO, and other styles

4

SCACIOTA, Ana Carolina Lemes, Delcio MATOS, Manuelle Mastrorocco Brand ROSA, Mileny Esbravatti Stephano COLOVATI, Elisa Fatima Benavent Caldas BELLOTTO, and Ana Luiza Cabrera MARTIMBIANCO. "INTERVENTIONS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME: A REVIEW OF COCHRANE SYSTEMATIC REVIEWS." Arquivos de Gastroenterologia 58, no. 1 (March 2021): 120–26. http://dx.doi.org/10.1590/s0004-2803.202100000-20.

Full text

Abstract:

ABSTRACT BACKGROUND: Irritable bowel syndrome (IBS) is a complex gastrointestinal disorder, whose understanding is relatively uncertain, and the treatment guidance decision still represents a challenge. OBJECTIVE: To identify and critically appraise systematic reviews (SRs) published in the Cochrane Database of SRs (CDSR) on the effects of interventions (pharmacological and non-pharmacological) for the treatment of IBS. METHODS: The search was conducted at the Cochrane Library in May 2020. The methodological quality of the SRs was evaluated by the AMSTAR-2 tool. RESULTS: Eight SRs with moderate to high quality were included, which addressed the treatments: (a) pharmacological: volume agents, antispasmodics, antidepressants and tegaserod; and (b) non-pharmacological: homeopathy, acupuncture, phytotherapy, biofeedback, psychological interventions and hypnotherapy. The results were favorable to antispasmodic drugs and antidepressants regarding the improvement of clinical symptoms. There was no difference between volume agents or tegaserod when compared to placebo. Acupuncture and homeopathy showed a little improvement in symptoms compared to placebo, but the certainty of this evidence was considered low to very low. Psychological interventions seem to improve the overall assessment of the patient and relief symptoms such as abdominal pain. However, there was no long-term follow-up of these patients. The results of the other treatments were considered uncertain due to the high risk of bias. CONCLUSION: Considering the low quality of the studies included in the SRs, pharmacological treatment with antispasmodics and antidepressants seems to be beneficial for patients with IBS. Among non-pharmacological interventions, psychological interventions seem to be beneficial. However, further clinical trials are recommended with greater methodological rigor to prove these findings.

APA, Harvard, Vancouver, ISO, and other styles

5

Marsh, T. Donald. "Irritable Bowel Syndrome." Journal of Pharmacy Practice 12, no. 6 (December 1999): 462–71. http://dx.doi.org/10.1177/089719009901200605.

Full text

Abstract:

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder. Abdominal pain or discomfort relieved by bowel movements and worsened by stress suggest a brain/gut disorder. Associated factors include a history of affective disorders, sexual or physical abuse, low fiber intake, certain foods, and drugs. Diagnosis is one of exclusion and is based on the Rome Criteria. Symptom control is a reasonable treatment goal using fiber-containing foods, bulk laxatives, antidiarrheals, and antispasmodics. Tricyclic antidepressants may relieve unremitting pain and improve daily functioning. Other measures include patient education and reassurance, behavioral therapy, reduction of stress, and inclusion of the patient and family in the treatment plan.

APA, Harvard, Vancouver, ISO, and other styles

6

El-Salhy, Magdy, Doris Gundersen, Jan Gunnar Hatlebakk, and Trygve Hausken. "Irritable bowel syndrome: treatment options." Clinical Practice 9, no. 5 (September 2012): 591–600. http://dx.doi.org/10.2217/cpr.12.41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Basnayake, Chamara. "Treatment of irritable bowel syndrome." Australian Prescriber 41, no. 5 (October 2, 2018): 145–49. http://dx.doi.org/10.18773/austprescr.2018.044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Farthing, Michael J. G. "Treatment of irritable bowel syndrome." BMJ 330, no. 7489 (February 24, 2005): 429–30. http://dx.doi.org/10.1136/bmj.330.7489.429.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Trinkley, K. E., and M. C. Nahata. "Treatment of irritable bowel syndrome." Journal of Clinical Pharmacy and Therapeutics 36, no. 3 (August 24, 2010): 275–82. http://dx.doi.org/10.1111/j.1365-2710.2010.01177.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Spiller, Robin C. "Treatment of irritable bowel syndrome." Current Treatment Options in Gastroenterology 6, no. 4 (August 2003): 329–37. http://dx.doi.org/10.1007/s11938-003-0025-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

LUPU, Vasile Valeriu, Andrada DRUICĂ, Ancuţa IGNAT, Irina Manuela MUCENICA, Oana Tatiana MIRON, Letiţia Doina DUCEAC, Felicia DRĂGAN, Brânduşa Alina PETRE, and Marin BURLEA. "Irritable bowel syndrome." Romanian Journal of Medical Practice 11, no. 1 (March 31, 2016): 33–36. http://dx.doi.org/10.37897/rjmp.2016.1.6.

Full text

Abstract:

Irritable bowel syndrome (IBS) is not a disease. It is a group of symptoms that occur together, symptoms as: chronic or recurrent abdominal pain, altered bowel habits, and bloating, with the absence of structural or biochemical abnormalities. Irritable bowel syndrome is a functional gastrointestinal disorder. The causes of IBS are poorly understood. Limited information is available about the number of children with IBS. IBS affects boys and girls equally, but affects each person differently. IBS can be very difficult to diagnose. IBS is diagnosed by exclusion. To diagnose IBS, a health care provider will conduct a physical exam and take a complete medical history. The main objective of treatment for IBS is to restore normal daily function. Diet and lifestyle changes are important in decreasing the frequency and severity of IBS symptoms. Irritable bowel syndrome is a long-term disease and symptoms usually recur. This may be influenced by factors such as stress, diet or other environmental causes. Avoiding triggers is the best way to prevent symptoms of IBS. However, based on the symptoms, this disease can be confused with other organic bowel diseases.

APA, Harvard, Vancouver, ISO, and other styles

12

Bafutto, Mauro, José Roberto de Almeida, Nayle Vilela Leite, Enio Chaves Oliveira, Salustiano Gabriel-Neto, and Joffre Rezende-Filho. "Treatment of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with mesalazine." Arquivos de Gastroenterologia 48, no. 1 (March 2011): 36–40. http://dx.doi.org/10.1590/s0004-28032011000100008.

Full text

Abstract:

CONTEXT: Recent studies support the hypothesis that postinfectious irritable bowel syndrome and some irritable bowel syndrome patients display persistent signs of minor mucosal inflammation. Mesalazine has intestinal anti-inflammatory properties including cyclooxygenase and prostaglandin inhibition. The effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome patients are still unknown. OBJECTIVE: To observe the effects of mesalazine on postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients. METHODS: Based on Rome III criteria, 61 irritable bowel syndrome with diarrhea patients (18 years old or more) were included in the evaluation. Patients were divided into two groups: postinfectious irritable bowel syndrome group, with 18 patients medicated with mesalazine 800 mg 3 times a day for 30 days; noninfective irritable bowel syndrome group, with 43 patients medicated with mesalazine 800 mg 3 times a day for 30 days. Symptom evaluations at baseline and after treatment were performed by means of a four-point Likert scale including stool frequency, stool form and consistency (Bristol Stool Scale), abdominal pain and distension (maximum score: 16; minimum score: 4). RESULTS: Postinfectious irritable bowel syndrome group presented a statistically significant reduction of the total symptom score (P<0.0001). The stool frequency was significantly reduced (P<0.0001), and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distension were significantly reduced (P<0.0001). Noninfective irritable bowel syndrome group presented a statistically significant reduction of total symptom score (P<0.0001). Also, the stool frequency was significantly reduced (P<0.0001) and stool consistency, improved (P<0.0001). Abdominal pain (P<0.0001) and abdominal distention were significantly reduced (P<0.0001). There was no statistical difference between postinfectious irritable bowel syndrome group and noninfective irritable bowel syndrome group on total symptom score results at 30th day of therapy with mesalazine 800 mg 3 times a day. (P = 0.13). CONCLUSION: Mesalazine reduced key symptoms of postinfectious irritable bowel syndrome and noninfective irritable bowel syndrome with diarrhea patients.

APA, Harvard, Vancouver, ISO, and other styles

13

Somers, Samuel C., and Anthony Lembo. "Irritable bowel syndrome: evaluation and treatment." Gastroenterology Clinics of North America 32, no. 2 (June 2003): 507–29. http://dx.doi.org/10.1016/s0889-8553(03)00022-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Reina, Jason, and James W. Smith. "Medical Treatment of Irritable Bowel Syndrome." Clinics in Colon and Rectal Surgery 18, no. 02 (May 2005): 102–8. http://dx.doi.org/10.1055/s-2005-870891.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Shan, Yaso. "Irritable bowel syndrome: treatment and management." Primary Health Care 19, no. 8 (October 2009): 28–34. http://dx.doi.org/10.7748/phc2009.10.19.8.28.c7302.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Harmon, Heidi W. "Treatment Options for Irritable Bowel Syndrome." Nurse Practitioner 32, no. 7 (July 2007): 39–43. http://dx.doi.org/10.1097/01.npr.0000279571.93570.cb.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Schneider, A. "Acupuncture treatment in irritable bowel syndrome." Gut 55, no. 5 (May 1, 2006): 649–54. http://dx.doi.org/10.1136/gut.2005.074518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Fireman, Zvi, Arieh Segal, Yael Kopelman, Amos Sternberg, and Rafael Carasso. "Acupuncture Treatment for Irritable Bowel Syndrome." Digestion 64, no. 2 (2001): 100–103. http://dx.doi.org/10.1159/000048847.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Dill, James E., and Bobbie P. Dill. "Biopsychosocial treatment of irritable bowel syndrome." Gastroenterology 125, no. 5 (November 2003): 1554. http://dx.doi.org/10.1016/j.gastro.2003.04.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Heitkemper, Margaret, and Monica Jarrett. "Irritable Bowel Syndrome: Causes and Treatment." Gastroenterology Nursing 23, no. 6 (November 2000): 256–63. http://dx.doi.org/10.1097/00001610-200011000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

&NA;. "Irritable Bowel Syndrome: Causes and Treatment." Gastroenterology Nursing 24, no. 1 (January 2001): 37. http://dx.doi.org/10.1097/00001610-200101000-00009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Thompson, W. G. "The treatment of irritable bowel syndrome." Alimentary Pharmacology & Therapeutics 16, no. 8 (August 2002): 1395–406. http://dx.doi.org/10.1046/j.1365-2036.2002.01312.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Blanchard, Edward B., and Howard S. Malamood. "Psychological treatment of irritable bowel syndrome." Professional Psychology: Research and Practice 27, no. 3 (1996): 241–44. http://dx.doi.org/10.1037/0735-7028.27.3.241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bjarnason, Ingvar. "Unorthodox treatment for irritable bowel syndrome?" European Journal of Gastroenterology & Hepatology 17, no. 1 (January 2005): 1–3. http://dx.doi.org/10.1097/00042737-200501000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Winslet, M. C. "Irritable Bowel Syndrome Diagnosis and Treatment." Colorectal Disease 6, no. 2 (March 2004): 135. http://dx.doi.org/10.1111/j.1462-8910.2004.00634.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Ahmad, O. F., and A. Akbar. "Dietary treatment of irritable bowel syndrome." British Medical Bulletin 113, no. 1 (January 19, 2015): 83–90. http://dx.doi.org/10.1093/bmb/ldu039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Mabel, J. A. "Treatment Protocols for Irritable Bowel Syndrome." Journal of the American Dietetic Association 110, no. 9 (September 2010): A43. http://dx.doi.org/10.1016/j.jada.2010.06.165.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Farthing, Michael J. G. "Treatment options in irritable bowel syndrome." Best Practice & Research Clinical Gastroenterology 18, no. 4 (August 2004): 773–86. http://dx.doi.org/10.1016/j.bpg.2004.04.008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Friedman, Gerald. "Treatment of the Irritable Bowel Syndrome." Gastroenterology Clinics of North America 20, no. 2 (June 1991): 325–33. http://dx.doi.org/10.1016/s0889-8553(21)00554-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Соловйова, Г. А., К. Л. Кваченюк, and К. В. Філоненко. "Irritable Bowel Syndrome: Diagnostic and Treatment Algorithms." Family Medicine, no. 4 (October 30, 2018): 88–98. http://dx.doi.org/10.30841/2307-5112.4.2018.161563.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Соловйова, Г. А., К. Л. Кваченюк, and К. В. Філоненко. "Aspazmin in the treatment irritable bowel syndrome." Family Medicine, no. 5(73) (November 30, 2017): 92–100. http://dx.doi.org/10.30841/2307-5112.5(73).2017.123193.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Choi, Myung-Gyu. "Diagnosis and Treatment of Irritable Bowel Syndrome." Journal of the Korean Medical Association 46, no. 7 (2003): 612. http://dx.doi.org/10.5124/jkma.2003.46.7.612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Dunphy, Rebecca C., and G. Nicholas Verne. "Drug Treatment Options for Irritable Bowel Syndrome." Drugs & Aging 18, no. 3 (2001): 201–11. http://dx.doi.org/10.2165/00002512-200118030-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Hovdenak, Nils. "Loperamide Treatment of the Irritable Bowel Syndrome." Scandinavian Journal of Gastroenterology 22, sup130 (January 1987): 81–84. http://dx.doi.org/10.3109/00365528709091004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bikash, Gupta, Dash Biswajit, Paul Sujata, and Bora Jyoti Aditya. "TREATMENT OF IRRITABLE BOWEL SYNDROME: A REVIEW." Asian Journal of Pharmaceutical and Clinical Research 11, no. 9 (September 7, 2018): 46. http://dx.doi.org/10.22159/ajpcr.2018.v11i9.25953.

Full text

Abstract:

Irritable bowel syndrome (IBS) is a gastrointestinal disease which is also called as spastic colon, mucous colitis is characterized by some non-specific symptoms, such as altered bowel habits and abdominal pain, stomach bloating, chronic diarrhea or constipation or alternating between the two. The therapy is based on the healing of symptoms using various pharmaceutical and non-pharmaceutical agents. The objective of treatment is relief from symptom and improved quality of life. The approach for the treatment of IBS is based on the predominant symptoms of the patient. Classical as well as alternative treatment, both appear to be effective for the patients. Classical treatments basically consist of antidiarrheal, antidepressants, antispasmodic, bulking agents, osmotic laxatives, etc. Still, herbal or alternative treatment always seems to be the same beneficiary for the patients due to their negligible adverse effect.

APA, Harvard, Vancouver, ISO, and other styles

36

Hutton, Jane. "Irritable bowel syndrome: psychosocial assessment and treatment." Behaviour Research and Therapy 41, no. 4 (April 2003): 505–6. http://dx.doi.org/10.1016/s0005-7967(02)00143-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Lachenmeyer, Juliana, and Richard S. Deucher. "Cognitive–behavioral treatment of irritable bowel syndrome." Journal of Psychosomatic Research 51, no. 6 (December 2001): 767. http://dx.doi.org/10.1016/s0022-3999(01)00276-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Pattee, P. L., and W. G. Thompson. "Drug Treatment of the Irritable Bowel Syndrome." Drugs 44, no. 2 (August 1992): 200–206. http://dx.doi.org/10.2165/00003495-199244020-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hammerle, Christopher W., and Christina M. Surawicz. "Updates on treatment of irritable bowel syndrome." World Journal of Gastroenterology 14, no. 17 (2008): 2639. http://dx.doi.org/10.3748/wjg.14.2639.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Toner, Brenda B. "Cognitive-Behavioral Treatment of Irritable Bowel Syndrome." CNS Spectrums 10, no. 11 (November 2005): 883–90. http://dx.doi.org/10.1017/s1092852900019854.

Full text

Abstract:

ABSTRACTThere is increasing evidence that supports the view that irritable bowel disorder (IBS) is a disorder of brain-gut function. Cognitive-behavioral therapy (CBT) has received increased attention in light of this recent shift in the conceptualization of IBS. This review has two main aims. The first is to provide a critical review of controlled trials on CBT for IBS. The second is to discuss ways of further developing CBT interventions that are more clinically relevant and meaningful to health care providers and individuals with a diagnosis of IBS. A theme from a CBT intervention will be presented to illustrate how CBT interventions can be incorporated within a larger social context. A review of CBT for IBS lends some limited support for improvement in some IBS symptoms and associated psychosocial distress. This conclusion needs to be expressed with some caution, however, in light of many methodological shortcomings including small sample sizes, inadequate control conditions and failure to identify primary versus secondary outcome measures. In addition, future studies will need to further develop more relevant CBT protocols that more fully integrate the patient's perspective and challenge social cognitions about this stigmatized disorder.

APA, Harvard, Vancouver, ISO, and other styles

41

Lacy, Brian E., Kirsten Weiser, and Ryan De Lee. "Review: The treatment of irritable bowel syndrome." Therapeutic Advances in Gastroenterology 2, no. 4 (June 8, 2009): 221–38. http://dx.doi.org/10.1177/1756283x09104794.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Jailwala, Jeegar. "Pharmacologic Treatment of the Irritable Bowel Syndrome." Annals of Internal Medicine 133, no. 2 (July 18, 2000): 136. http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Gamble, Jon. "Irritable Bowel Syndrome: A New Treatment Paradigm." Homoeopathic Links 21, no. 03 (2008): 128–34. http://dx.doi.org/10.1055/s-2008-1038802.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Dalton, C. B., and D. A. Drossman. "Diagnosis and treatment of irritable bowel syndrome." Drugs of Today 34, no. 7 (1998): 585. http://dx.doi.org/10.1358/dot.1998.34.7.484111.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Deng, Zhen-Hua, and Jiang Chang. "Progress in treatment of irritable bowel syndrome." World Chinese Journal of Digestology 24, no. 19 (2016): 3009. http://dx.doi.org/10.11569/wcjd.v24.i19.3009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Whorwell, Peter, and Richard Lea. "Dietary treatment of the irritable bowel syndrome." Current Treatment Options in Gastroenterology 7, no. 4 (August 2004): 307–16. http://dx.doi.org/10.1007/s11938-004-0017-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tsynman, Donald N., Savanna Thor, and Joyann A. Kroser. "Treatment of Irritable Bowel Syndrome in Women." Gastroenterology Clinics of North America 40, no. 2 (June 2011): 265–90. http://dx.doi.org/10.1016/j.gtc.2011.03.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Svedlund, Jan. "Psychological treatment for the irritable bowel syndrome." Gastroenterology 102, no. 2 (February 1992): 739–40. http://dx.doi.org/10.1016/0016-5085(92)90139-p.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Drossman, Douglas A., and Betsy C. Lowman. "Irritable Bowel Syndrome: Epidemiology, Diagnosis and Treatment." Clinics in Gastroenterology 14, no. 3 (July 1985): 559–73. http://dx.doi.org/10.1016/s0300-5089(21)00724-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Camilleri, Michael. "Diagnosis and Treatment of Irritable Bowel Syndrome." JAMA 325, no. 9 (March 2, 2021): 865. http://dx.doi.org/10.1001/jama.2020.22532.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!